Roche Posts Encouraging Follow-up Data From Tiragolumab/Tecentriq Trial In Lung Cancer
Roche Holdings AG (OTC: RHHBY) reported
Europe Approves Roche’s Tocilizumab For Patients With Severe COVID-19
The European Commission has extended the marketing authorization for Roche Holdings AG’s (OTC:RHHBY) Actemra/RoActemra (Tocilizumab) to treat patients with severe…
Gene Therapy-Focused Dyno Therapeutics Adds Astellas To List Partner List With $1.6B Pact
Gene therapy startup Dyno Therapeutics Inc has partnered with pharmaceutical giants such as Novartis AG (NYSE: NVS) and Roche Holdings AG (OTC: RHHBY).
Roche’s Gavreto Conditionally Approved In Europe For RET Fusion-Positive Lung Cancer
The European Commission (EC) has granted conditional marketing authorization to Roche
Spark Therapeutics’ Hemophilia Gene Therapy Shows Reduction In Bleeding Episodes
Spark Therapeutics, a unit of Roche Holdings AG (OTC:RHHBY), has announced data from its Phase 1/2 trial of SPK-8011 in hemophilia A. …
Europe Approves Regeneron – Roche’s COVID-19 Antibody Cocktail
The European Commission (EC) has approved Regeneron Pharmaceuticals Inc’s (NASDAQ:REGN) COVID-19 antibody cocktail, known as REGEN-COV in the U.S. and Ronapreve…
Hit By Slow Rollout, Biogen’s Aduhelm Could Soon Find Itself In Price Competition: Reuters
With already a snail-paced rollout of Biogen Inc's (NASDAQ: BIIB) controversial Alzheimer's treatment Aduhelm, the Company could soon face price competition.
ALX Oncology Falls After Updated Data For Solid Tumors Candidate
ALX Oncology Holdings Inc (NASDAQ:ALXO) released additional data from a phase 1b trial of evorpacept in solid tumor malignancies. One cohort…
Regeneron-Roche’s COVID-19 Treatment Shows Long Term Benefit After Single Dose
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has announced additional results from a Phase 3 trial, which assessed a single dose of REGEN-COV (1,200…
Novartis To Offload Its Stake Back To Roche For $20.7B
Novartis AG (NYSE:NVS), a shareholder in Roche Holdings AG (OTC:RHHBY) for more than 20 years, would sell its entire stake, which is…